Simple Summary Hepatocellular carcinoma (HCC) is a common malignancy worldwide. The
HCC generally develops in the liver of patients already suffering from chronic liver disease …

The Janus kinase (JAK)–signal transducer of activators of transcription (STAT) pathway is
now recognized as an evolutionarily conserved signaling pathway employed by diverse …

Cancer progression results from activation of various signaling networks. Among these,
PI3K/Akt signaling contributes to proliferation, invasion, and inhibition of apoptosis …

Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in
various cancers and plays a crucial role in oncogensis, including the activation of genes …

The Janus kinase (JAK)/signal transducer and activator of transcription (STAT) signaling
pathway is characterized by diverse immune regulatory systems involving cell proliferation …

Hepatocellular carcinoma (HCC) is the most common primary liver cancer whose incidence
continues to rise in many parts of the world due to a concomitant rise in many associated risk …

Li Y, Chen G, Han Z, Cheng H, Qiao L, Li Y. Onco Targets Ther. 2020; 13: 9721–9730. The
Editor and Publisher of OncoTargets and Therapy wish to retract the published article …

Janus kinase/signal transducers and activators of transcription (JAK/STAT) signaling is one
of the major pathways for cytokine signal transduction. However, the role of the JAK/STAT …

Breast cancer is the most common malignant tumor in women worldwide. Traditional ways of
treatment, including radiotherapy and endocrine therapy, for breast cancer have inevitable …

Hepatocellular carcinoma (HCC) has become the second leading cause of cancer related
death, with an increasing death rate in recent years. For advanced HCC, sorafenib is the first …